using a congenic mouse model , we demonstrated that human ril-2 ( as an adjuvant ) can overcome ir gene controlled low immune responsiveness to peptide malaria ag vaccine candidates [ r32tet32 , r32lr , and th2r-np ( nanp ) 5na ] as determined by the antibody response , providing it is emulsified with the ag during immunization .
C0086418
human
C1706141
np